nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—stomach cancer—gallbladder cancer	0.265	0.517	CtDrD
Docetaxel—BCL2—gallbladder cancer	0.262	0.604	CbGaD
Docetaxel—pancreatic cancer—gallbladder cancer	0.248	0.483	CtDrD
Docetaxel—EGFR—gallbladder cancer	0.172	0.395	CbGaD
Docetaxel—ABCC2—bile duct—gallbladder cancer	0.00326	0.139	CbGeAlD
Docetaxel—Paclitaxel—BCL2—gallbladder cancer	0.00264	1	CrCbGaD
Docetaxel—ABCC2—bile—gallbladder cancer	0.0025	0.107	CbGeAlD
Docetaxel—KIF11—lymph node—gallbladder cancer	0.000882	0.0377	CbGeAlD
Docetaxel—BCL2—epithelium—gallbladder cancer	0.000851	0.0363	CbGeAlD
Docetaxel—MAP4—pancreas—gallbladder cancer	0.000834	0.0356	CbGeAlD
Docetaxel—NR1I2—liver—gallbladder cancer	0.000811	0.0346	CbGeAlD
Docetaxel—MAP2—pancreas—gallbladder cancer	0.000657	0.028	CbGeAlD
Docetaxel—MAP4—liver—gallbladder cancer	0.000531	0.0227	CbGeAlD
Docetaxel—MAPT—lymph node—gallbladder cancer	0.000517	0.0221	CbGeAlD
Docetaxel—TUBB6—epithelium—gallbladder cancer	0.000511	0.0218	CbGeAlD
Docetaxel—TUBB4A—pancreas—gallbladder cancer	0.000507	0.0217	CbGeAlD
Docetaxel—TUBB2B—pancreas—gallbladder cancer	0.00049	0.0209	CbGeAlD
Docetaxel—EGFR—liver—gallbladder cancer	0.000477	0.0204	CbGeAlD
Docetaxel—SLCO1B3—liver—gallbladder cancer	0.000464	0.0198	CbGeAlD
Docetaxel—TUBB—pancreas—gallbladder cancer	0.000464	0.0198	CbGeAlD
Docetaxel—TUBB2A—pancreas—gallbladder cancer	0.000462	0.0197	CbGeAlD
Docetaxel—TUBB6—pancreas—gallbladder cancer	0.000455	0.0194	CbGeAlD
Docetaxel—MAP2—liver—gallbladder cancer	0.000418	0.0178	CbGeAlD
Docetaxel—MAP4—lymph node—gallbladder cancer	0.000407	0.0174	CbGeAlD
Docetaxel—TUBB4B—pancreas—gallbladder cancer	0.000396	0.0169	CbGeAlD
Docetaxel—CYP3A7—liver—gallbladder cancer	0.000392	0.0167	CbGeAlD
Docetaxel—BCL2—lymph node—gallbladder cancer	0.00037	0.0158	CbGeAlD
Docetaxel—EGFR—lymph node—gallbladder cancer	0.000365	0.0156	CbGeAlD
Docetaxel—SLC22A7—liver—gallbladder cancer	0.000361	0.0154	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—liver—gallbladder cancer	0.000333	0.0142	CbGeAlD
Docetaxel—TUBB4A—liver—gallbladder cancer	0.000323	0.0138	CbGeAlD
Docetaxel—MAP2—lymph node—gallbladder cancer	0.00032	0.0137	CbGeAlD
Docetaxel—TUBB—liver—gallbladder cancer	0.000295	0.0126	CbGeAlD
Docetaxel—TUBB2A—liver—gallbladder cancer	0.000294	0.0125	CbGeAlD
Docetaxel—TUBB6—liver—gallbladder cancer	0.00029	0.0124	CbGeAlD
Docetaxel—ABCC10—liver—gallbladder cancer	0.000254	0.0108	CbGeAlD
Docetaxel—TUBB4B—liver—gallbladder cancer	0.000252	0.0108	CbGeAlD
Docetaxel—TUBB4A—lymph node—gallbladder cancer	0.000248	0.0106	CbGeAlD
Docetaxel—TUBB2B—lymph node—gallbladder cancer	0.000239	0.0102	CbGeAlD
Docetaxel—TUBB—lymph node—gallbladder cancer	0.000226	0.00967	CbGeAlD
Docetaxel—TUBB2A—lymph node—gallbladder cancer	0.000225	0.00962	CbGeAlD
Docetaxel—TUBB6—lymph node—gallbladder cancer	0.000222	0.00949	CbGeAlD
Docetaxel—CYP3A5—pancreas—gallbladder cancer	0.000217	0.00925	CbGeAlD
Docetaxel—ABCC2—liver—gallbladder cancer	0.000204	0.0087	CbGeAlD
Docetaxel—CYP1B1—liver—gallbladder cancer	0.000199	0.00852	CbGeAlD
Docetaxel—ABCC10—lymph node—gallbladder cancer	0.000194	0.00831	CbGeAlD
Docetaxel—TUBB4B—lymph node—gallbladder cancer	0.000193	0.00825	CbGeAlD
Docetaxel—ABCC1—liver—gallbladder cancer	0.000179	0.00766	CbGeAlD
Docetaxel—ABCC2—lymph node—gallbladder cancer	0.000156	0.00667	CbGeAlD
Docetaxel—CYP1B1—lymph node—gallbladder cancer	0.000153	0.00653	CbGeAlD
Docetaxel—ABCG2—liver—gallbladder cancer	0.000149	0.00634	CbGeAlD
Docetaxel—CYP3A5—liver—gallbladder cancer	0.000138	0.00589	CbGeAlD
Docetaxel—ABCC1—lymph node—gallbladder cancer	0.000138	0.00587	CbGeAlD
Docetaxel—ABCB1—epithelium—gallbladder cancer	0.000129	0.00552	CbGeAlD
Docetaxel—ABCB1—pancreas—gallbladder cancer	0.000115	0.00492	CbGeAlD
Docetaxel—ABCG2—lymph node—gallbladder cancer	0.000114	0.00486	CbGeAlD
Docetaxel—CYP3A4—liver—gallbladder cancer	0.000103	0.00442	CbGeAlD
Docetaxel—ABCB1—liver—gallbladder cancer	7.32e-05	0.00313	CbGeAlD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	6.12e-05	0.00227	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—KRAS—gallbladder cancer	6.11e-05	0.00226	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	6.06e-05	0.00224	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TP53—gallbladder cancer	6.05e-05	0.00224	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—EGFR—gallbladder cancer	6.05e-05	0.00224	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB3—gallbladder cancer	6.03e-05	0.00223	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TP53—gallbladder cancer	6.03e-05	0.00223	CbGpPWpGaD
Docetaxel—EGFR—a6b1 and a6b4 Integrin signaling—HRAS—gallbladder cancer	6.01e-05	0.00223	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NRAS—gallbladder cancer	5.98e-05	0.00221	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	5.91e-05	0.00219	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB4—gallbladder cancer	5.9e-05	0.00218	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—KRAS—gallbladder cancer	5.89e-05	0.00218	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—TP53—gallbladder cancer	5.87e-05	0.00217	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—ERBB2—gallbladder cancer	5.8e-05	0.00215	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—KRAS—gallbladder cancer	5.77e-05	0.00214	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—ERBB2—gallbladder cancer	5.77e-05	0.00214	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—ERBB3—gallbladder cancer	5.76e-05	0.00213	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB3—gallbladder cancer	5.76e-05	0.00213	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—ERBB3—gallbladder cancer	5.76e-05	0.00213	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	5.75e-05	0.00213	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—KRAS—gallbladder cancer	5.71e-05	0.00211	CbGpPWpGaD
Docetaxel—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—gallbladder cancer	5.71e-05	0.00211	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—ERBB3—gallbladder cancer	5.71e-05	0.00211	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—ERBB3—gallbladder cancer	5.66e-05	0.00209	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—ERBB2—gallbladder cancer	5.66e-05	0.00209	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—ERBB3—gallbladder cancer	5.63e-05	0.00209	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—HRAS—gallbladder cancer	5.62e-05	0.00208	CbGpPWpGaD
Docetaxel—ABCB1—lymph node—gallbladder cancer	5.61e-05	0.0024	CbGeAlD
Docetaxel—EGFR—GAB1 signalosome—ERBB2—gallbladder cancer	5.61e-05	0.00208	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—gallbladder cancer	5.48e-05	0.00203	CbGpPWpGaD
Docetaxel—KIF11—Immune System—BCL2—gallbladder cancer	5.45e-05	0.00202	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	5.44e-05	0.00201	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—TP53—gallbladder cancer	5.43e-05	0.00201	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TP53—gallbladder cancer	5.4e-05	0.002	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KEAP1—gallbladder cancer	5.37e-05	0.00199	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ERBB4—gallbladder cancer	5.37e-05	0.00199	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—ERBB3—gallbladder cancer	5.33e-05	0.00197	CbGpPWpGaD
Docetaxel—KIF11—Immune System—ERBB2—gallbladder cancer	5.29e-05	0.00196	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—gallbladder cancer	5.24e-05	0.00194	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KEAP1—gallbladder cancer	5.23e-05	0.00194	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—HRAS—gallbladder cancer	5.2e-05	0.00192	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—HRAS—gallbladder cancer	5.16e-05	0.00191	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—KRAS—gallbladder cancer	5.14e-05	0.0019	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—EGFR—gallbladder cancer	5.11e-05	0.00189	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB3—gallbladder cancer	5.1e-05	0.00189	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—NRAS—gallbladder cancer	5.08e-05	0.00188	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—HRAS—gallbladder cancer	5.01e-05	0.00186	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—HRAS—gallbladder cancer	4.91e-05	0.00182	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HRAS—gallbladder cancer	4.86e-05	0.0018	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	4.81e-05	0.00178	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ERBB3—gallbladder cancer	4.64e-05	0.00172	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—gallbladder cancer	4.57e-05	0.00169	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	4.54e-05	0.00168	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—ERBB4—gallbladder cancer	4.54e-05	0.00168	CbGpPWpGaD
Docetaxel—EGFR—LPA receptor mediated events—HRAS—gallbladder cancer	4.54e-05	0.00168	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—BCL2—gallbladder cancer	4.48e-05	0.00166	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—ERBB4—gallbladder cancer	4.38e-05	0.00162	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—KRAS—gallbladder cancer	4.38e-05	0.00162	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—HRAS—gallbladder cancer	4.37e-05	0.00162	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—ERBB2—gallbladder cancer	4.33e-05	0.0016	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—TP53—gallbladder cancer	4.29e-05	0.00159	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	4.22e-05	0.00156	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—NRAS—gallbladder cancer	4.17e-05	0.00154	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—ERBB2—gallbladder cancer	4.14e-05	0.00153	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—ERBB2—gallbladder cancer	4.08e-05	0.00151	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	4.04e-05	0.00149	CbGpPWpGaD
Docetaxel—KIF11—Immune System—NRAS—gallbladder cancer	4.03e-05	0.00149	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—EGFR—gallbladder cancer	4e-05	0.00148	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	3.98e-05	0.00147	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—gallbladder cancer	3.95e-05	0.00146	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—ERBB3—gallbladder cancer	3.92e-05	0.00145	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—ERBB2—gallbladder cancer	3.9e-05	0.00144	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—TP53—gallbladder cancer	3.89e-05	0.00144	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—ERBB2—gallbladder cancer	3.88e-05	0.00144	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	3.88e-05	0.00144	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—ERBB2—gallbladder cancer	3.86e-05	0.00143	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—ERBB2—gallbladder cancer	3.84e-05	0.00142	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—ERBB3—gallbladder cancer	3.79e-05	0.0014	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—gallbladder cancer	3.78e-05	0.0014	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	3.76e-05	0.00139	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—NRAS—gallbladder cancer	3.75e-05	0.00139	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—HRAS—gallbladder cancer	3.72e-05	0.00138	CbGpPWpGaD
Docetaxel—KIF11—Immune System—EGFR—gallbladder cancer	3.67e-05	0.00136	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	3.61e-05	0.00134	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—ERBB2—gallbladder cancer	3.61e-05	0.00134	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—ERBB2—gallbladder cancer	3.61e-05	0.00134	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—KRAS—gallbladder cancer	3.59e-05	0.00133	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—ERBB2—gallbladder cancer	3.58e-05	0.00133	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	3.55e-05	0.00131	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—ERBB2—gallbladder cancer	3.53e-05	0.00131	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—BCL2—gallbladder cancer	3.51e-05	0.0013	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	3.5e-05	0.00129	CbGpPWpGaD
Docetaxel—KIF11—Immune System—KRAS—gallbladder cancer	3.46e-05	0.00128	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—EGFR—gallbladder cancer	3.41e-05	0.00126	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—ERBB2—gallbladder cancer	3.41e-05	0.00126	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	3.4e-05	0.00126	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	3.34e-05	0.00124	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—ERBB2—gallbladder cancer	3.34e-05	0.00124	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—NRAS—gallbladder cancer	3.3e-05	0.00122	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—KRAS—gallbladder cancer	3.22e-05	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—HRAS—gallbladder cancer	3.21e-05	0.00119	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	3.2e-05	0.00118	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KEAP1—gallbladder cancer	3.17e-05	0.00117	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	3.15e-05	0.00117	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	3.15e-05	0.00117	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—NRAS—gallbladder cancer	3.1e-05	0.00115	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—HRAS—gallbladder cancer	3.05e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—NRAS—gallbladder cancer	2.96e-05	0.0011	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—NRAS—gallbladder cancer	2.95e-05	0.00109	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HRAS—gallbladder cancer	2.95e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—NRAS—gallbladder cancer	2.93e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—NRAS—gallbladder cancer	2.92e-05	0.00108	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ERBB2—gallbladder cancer	2.91e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—gallbladder cancer	2.91e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	2.88e-05	0.00107	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—NRAS—gallbladder cancer	2.86e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—KRAS—gallbladder cancer	2.84e-05	0.00105	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—NRAS—gallbladder cancer	2.75e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—NRAS—gallbladder cancer	2.75e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	2.75e-05	0.00102	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HRAS—gallbladder cancer	2.74e-05	0.00101	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—NRAS—gallbladder cancer	2.72e-05	0.00101	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	2.71e-05	0.001	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	2.71e-05	0.001	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	2.7e-05	0.000999	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—NRAS—gallbladder cancer	2.69e-05	0.000995	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	2.69e-05	0.000994	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—KRAS—gallbladder cancer	2.67e-05	0.000989	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB4—gallbladder cancer	2.59e-05	0.000958	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—KRAS—gallbladder cancer	2.55e-05	0.000944	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB4—gallbladder cancer	2.55e-05	0.000944	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—NRAS—gallbladder cancer	2.54e-05	0.000941	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	2.54e-05	0.00094	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—KRAS—gallbladder cancer	2.54e-05	0.00094	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—gallbladder cancer	2.54e-05	0.000939	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—KRAS—gallbladder cancer	2.53e-05	0.000935	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—KRAS—gallbladder cancer	2.51e-05	0.000931	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB4—gallbladder cancer	2.49e-05	0.00092	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	2.48e-05	0.000917	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—KRAS—gallbladder cancer	2.47e-05	0.000913	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—ERBB2—gallbladder cancer	2.46e-05	0.000911	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	2.43e-05	0.000901	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—HRAS—gallbladder cancer	2.41e-05	0.000893	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	2.39e-05	0.000884	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—ERBB2—gallbladder cancer	2.37e-05	0.000879	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—KRAS—gallbladder cancer	2.36e-05	0.000875	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	2.36e-05	0.000875	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—KRAS—gallbladder cancer	2.36e-05	0.000875	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	2.35e-05	0.000871	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—KRAS—gallbladder cancer	2.34e-05	0.000868	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	2.32e-05	0.00086	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—KRAS—gallbladder cancer	2.31e-05	0.000856	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	2.31e-05	0.000854	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—gallbladder cancer	2.27e-05	0.000841	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB3—gallbladder cancer	2.24e-05	0.000829	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ERBB2—gallbladder cancer	2.23e-05	0.000824	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	2.22e-05	0.000824	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NRAS—gallbladder cancer	2.21e-05	0.000819	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB3—gallbladder cancer	2.2e-05	0.000816	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—gallbladder cancer	2.19e-05	0.000811	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—KRAS—gallbladder cancer	2.19e-05	0.00081	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—gallbladder cancer	2.17e-05	0.000803	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—gallbladder cancer	2.16e-05	0.000799	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	2.16e-05	0.000799	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB3—gallbladder cancer	2.15e-05	0.000796	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—gallbladder cancer	2.15e-05	0.000795	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—gallbladder cancer	2.14e-05	0.000791	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	2.11e-05	0.00078	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	2.09e-05	0.000775	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	2.02e-05	0.000749	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—gallbladder cancer	2.02e-05	0.000746	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—gallbladder cancer	2.01e-05	0.000744	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	2.01e-05	0.000744	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—gallbladder cancer	2.01e-05	0.000744	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—gallbladder cancer	1.99e-05	0.000738	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	1.98e-05	0.000732	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	1.97e-05	0.000731	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—gallbladder cancer	1.97e-05	0.000728	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KRAS—gallbladder cancer	1.9e-05	0.000705	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—gallbladder cancer	1.9e-05	0.000703	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—gallbladder cancer	1.88e-05	0.000695	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—gallbladder cancer	1.87e-05	0.000693	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—gallbladder cancer	1.86e-05	0.000689	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—gallbladder cancer	1.81e-05	0.000669	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	1.78e-05	0.000659	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	1.77e-05	0.000654	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	1.72e-05	0.000637	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	1.72e-05	0.000635	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—gallbladder cancer	1.69e-05	0.000627	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—gallbladder cancer	1.69e-05	0.000627	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—gallbladder cancer	1.65e-05	0.000609	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—gallbladder cancer	1.62e-05	0.000599	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—gallbladder cancer	1.61e-05	0.000596	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ERBB2—gallbladder cancer	1.59e-05	0.000588	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—gallbladder cancer	1.55e-05	0.000576	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—gallbladder cancer	1.55e-05	0.000575	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB4—gallbladder cancer	1.51e-05	0.000558	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB4—gallbladder cancer	1.48e-05	0.000547	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—gallbladder cancer	1.46e-05	0.00054	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—BCL2—gallbladder cancer	1.44e-05	0.000535	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—gallbladder cancer	1.42e-05	0.000526	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB2—gallbladder cancer	1.4e-05	0.000519	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB4—gallbladder cancer	1.39e-05	0.000515	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB2—gallbladder cancer	1.38e-05	0.000512	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—gallbladder cancer	1.37e-05	0.000507	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB2—gallbladder cancer	1.35e-05	0.000499	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—gallbladder cancer	1.32e-05	0.000489	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB3—gallbladder cancer	1.3e-05	0.000483	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB3—gallbladder cancer	1.28e-05	0.000473	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—gallbladder cancer	1.24e-05	0.000459	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—gallbladder cancer	1.21e-05	0.000448	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB3—gallbladder cancer	1.2e-05	0.000446	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	1.19e-05	0.00044	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	1.12e-05	0.000416	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—gallbladder cancer	1.07e-05	0.000395	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—gallbladder cancer	1.05e-05	0.000389	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—gallbladder cancer	1.04e-05	0.000385	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—gallbladder cancer	1.03e-05	0.00038	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	9.98e-06	0.00037	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB4—gallbladder cancer	9.75e-06	0.000361	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—gallbladder cancer	9.58e-06	0.000355	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—gallbladder cancer	9.19e-06	0.00034	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—gallbladder cancer	9.05e-06	0.000335	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—gallbladder cancer	8.84e-06	0.000327	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—gallbladder cancer	8.82e-06	0.000327	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB3—gallbladder cancer	8.43e-06	0.000312	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2—gallbladder cancer	8.41e-06	0.000311	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—gallbladder cancer	8.17e-06	0.000303	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—gallbladder cancer	8.01e-06	0.000296	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—gallbladder cancer	7.81e-06	0.000289	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—gallbladder cancer	7.69e-06	0.000285	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—gallbladder cancer	7.55e-06	0.000279	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—gallbladder cancer	7.5e-06	0.000278	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—gallbladder cancer	6.8e-06	0.000252	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—gallbladder cancer	6.22e-06	0.00023	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—gallbladder cancer	6.09e-06	0.000225	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—gallbladder cancer	5.86e-06	0.000217	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—gallbladder cancer	5.74e-06	0.000213	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—gallbladder cancer	5.55e-06	0.000205	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—gallbladder cancer	5.35e-06	0.000198	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—gallbladder cancer	5.28e-06	0.000196	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—gallbladder cancer	5.24e-06	0.000194	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—gallbladder cancer	4.98e-06	0.000184	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—gallbladder cancer	4.94e-06	0.000183	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—gallbladder cancer	4.55e-06	0.000168	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—gallbladder cancer	4.46e-06	0.000165	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—gallbladder cancer	4.2e-06	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—gallbladder cancer	4.02e-06	0.000149	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—gallbladder cancer	3.46e-06	0.000128	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—gallbladder cancer	3.08e-06	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—gallbladder cancer	2.94e-06	0.000109	CbGpPWpGaD
